A distribution analysis of action potential parameters obtained from patch-clamped human stem cell-derived cardiomyocytes
Open Access
- 1 June 2016
- journal article
- Published by Elsevier in Journal of Pharmacological Sciences
- Vol. 131 (2) , 141-145
Abstract
No abstract availableKeywords
Funding Information
- New Energy and Industrial Technology Development Organization (NEDO) (P08030)
This publication has 13 references indexed in Scilit:
- A New Perspective in the Field of Cardiac Safety Testing through the Comprehensive In Vitro Proarrhythmia Assay ParadigmSLAS Discovery, 2016
- CiPA: Ongoing testing, future qualification procedures, and pending issuesJournal of Pharmacological and Toxicological Methods, 2015
- Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currentsJournal of Pharmacological and Toxicological Methods, 2014
- Assessment of Testing Methods for Drug-Induced Repolarization Delay and Arrhythmias in an iPS Cell–Derived Cardiomyocyte Sheet: Multi-site Validation StudyJournal of Pharmacological Sciences, 2014
- Revolution dawning in cardiotoxicity testingNature Reviews Drug Discovery, 2013
- On-chip constructive cell-Network study (I): Contribution of cardiac fibroblasts to cardiomyocyte beating synchronization and community effectJournal of Nanobiotechnology, 2011
- Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytesStem Cell Research, 2010
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Human Embryonic Stem Cells Develop Into Multiple Types of Cardiac MyocytesCirculation Research, 2003
- Differentiation of Human Embryonic Stem Cells to CardiomyocytesCirculation, 2003